U.S. Patent Office Approves World's First Heat-Stable Rotavirus Vaccine, an Industrial Info Market Brief

The United States Patent and Trademark Office (USPTO) has granted approval to Rotasiil, the world's first heat-stable rotavirus vaccine. It was developed by Serum Institute of India, which produces and sells more doses globally than any other vaccine manufacturer, and the National Institute of Allergy and Infectious Diseases (NIAID), part of the U.S. National Institutes of Health.



Read the Complete Article >>>

Details on this Article:
Industry Segment: Market Brief
Word Count: 132 Words
Attachment: India pharma plants 0819

Listen to Today's News

News Audio Library

Sync News Podcasts

Username:        Password:    

Related Articles

  Europe to See More Than $762 Million in First-Quarter Chemical Project Comp...

  DACH Region's Chemical Industry to Spend More Than $25 Million in Fourth-Qu...

  Egypt to Spend $20 Billion for Capital Chemical Projects, an Industrial Inf...

  India's Appliances, Consumer Electronics Market Expected to Grow by 9%, an ...

  Annual Financial Budget Gives Push to India's Shipping Sector, an Industria...